IDH2 and angioimmunoblastic T-cell lymphoma: AITL cases with IDH2(R172) mutations demonstrated a distinct gene expression signature characterized by downregulation of genes associated with TFH differentiation (e.g., STAT1 and IFNG) and enrichment of an interleukin 12-induced gene signature.